We are live on ! Find out more
SCMP

Sucampo Pharmaceuticals, Inc.
SCMP

Delisted

SCMP was delisted on the 12th of February, 2018.

Back to rankings

71 hedge funds and large institutions have $71.3M invested in Sucampo Pharmaceuticals, Inc. in 2014 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 24 increasing their positions, 28 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% less capital invested

Capital invested by funds: $79.9M → $71.3M (-$8.62M)

12% less funds holding

Funds holding: 81 → 71 (-10)

14% less repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 28

56% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 18

100% less call options, than puts

Call options by funds: $1K | Put options by funds: $269K

Holders
71
Holders Change
-10
Holders Change %
-12.35%
% of All Funds
2.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
24
Reduced
28
Closed
18
Calls
$1K
Puts
$269K
Net Calls
-$268K
Net Calls Change
+$793K

Top Buyers

Rank Fund Capital Flow
1
HVC
Healthcare Value Capital
New Jersey
+$683K
2
PAMU
Pictet Asset Management (UK)
United Kingdom
+$624K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$468K
4
CCMH
Cornerstone Capital Management Holdings
New York
+$437K
5
Two Sigma Investments
Two Sigma Investments
New York
+$388K

Top Sellers

Rank Fund Capital Flow
1
TC
TFS Capital
Pennsylvania
-$1.43M
2
BIT
BlackRock Institutional Trust
California
-$1.24M
3
Millennium Management
Millennium Management
New York
-$973K
4
BIM
Bogle Investment Management
Massachusetts
-$917K
5
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$723K
Name Holding Trade Value Shares
Change 		Change in
Stake
Wells Fargo
26
Wells Fargo
California
$420K -$145K -20,569 -25%
Two Sigma Investments
27
Two Sigma Investments
New York
$379K +$388K +54,932 New
MC
28
Menta Capital
California
$369K +$202K +28,600 +115%
AG
29
Algert Global
California
$358K +$367K +51,882 New
BIM
30
BlackRock Investment Management
Delaware
$343K +$85.3K +12,057 +32%
Charles Schwab
31
Charles Schwab
California
$301K +$99.7K +14,100 +48%
PM
32
Penbrook Management
New York
$295K -$683K -96,625 -69%
PCM
33
Prelude Capital Management
New York
$248K +$234K +33,100 +1,182%
ProShare Advisors
34
ProShare Advisors
Maryland
$245K -$76.9K -10,882 -23%
AllianceBernstein
35
AllianceBernstein
Tennessee
$241K +$1.24K +176 +0.5%
California State Teachers Retirement System (CalSTRS)
36
California State Teachers Retirement System (CalSTRS)
California
$224K +$55.2K +7,800 +32%
GC
37
Globeflex Capital
California
$207K -$566 -80 -0.3%
Invesco
38
Invesco
Georgia
$203K – – –
DekaBank Deutsche Girozentrale
39
DekaBank Deutsche Girozentrale
Germany
$176K -$7.07K -1,000 -4%
SIM
40
Spark Investment Management
New York
$164K +$170K +24,000 New
CS
41
Credit Suisse
Switzerland
$163K -$204K -28,832 -55%
TA
42
Teachers Advisors
New York
$153K +$7.67K +1,085 +5%
Morgan Stanley
43
Morgan Stanley
New York
$137K -$225K -31,883 -62%
Two Sigma Advisers
44
Two Sigma Advisers
New York
$111K +$114K +16,145 New
California Public Employees Retirement System
45
California Public Employees Retirement System
California
$105K – – –
ARTA
46
A.R.T. Advisors
New York
$101K -$182K -25,777 -64%
Goldman Sachs
47
Goldman Sachs
New York
$101K +$28.4K +4,016 +38%
Swiss National Bank
48
Swiss National Bank
Switzerland
$101K +$30.4K +4,300 +42%
RhumbLine Advisers
49
RhumbLine Advisers
Massachusetts
$99K +$10.8K +1,527 +12%
GC
50
Guggenheim Capital
Illinois
$95K -$28.1K -3,971 -22%
1
2
3 4

SCMP Hedge Fund Activity: Q2 2014 in Review

71 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in Sucampo Pharmaceuticals, Inc. (SCMP) for Q2 2014, worth a combined $71.3M — down 11% from $79.9M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of SCMP and 8 opened new positions — a net loss of 10 holders — while 28 trimmed existing stakes and 24 added.

The largest buyer was Healthcare Value Capital, opening a new position worth an estimated $683K. The largest seller was TFS Capital, cutting an estimated $1.43M.

  • 71 institutional investors held Sucampo Pharmaceuticals, Inc. (SCMP) as of Q2 2014, down from 81 in Q1 2014.
  • Funds reported $71.3M of Sucampo Pharmaceuticals, Inc. stock for Q2 2014, down 11% quarter-over-quarter.
  • 8 funds opened new Sucampo Pharmaceuticals, Inc. positions in Q2 2014 and 18 closed out, a net change of -10 holders.
  • The largest Sucampo Pharmaceuticals, Inc. buyer in Q2 2014 was Healthcare Value Capital, an estimated $683K added.
  • The largest Sucampo Pharmaceuticals, Inc. seller in Q2 2014 was TFS Capital, an estimated $1.43M sold.

Based on aggregated 13F filings for Q2 2014.